JOYCE KA SHUN PANG

Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine LAS VEGAS, NV NPI 1902160948

General Payments — all program years on this page

$673.91

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $544.11 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $486.6319
Education $57.481

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $129.801
2024 $544.1120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078902103 Actelion Pharmaceuticals US, Inc. $28.26 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902163 Actelion Pharmaceuticals US, Inc. $26.06 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104315144 AstraZeneca Pharmaceuticals LP $16.12 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104427957 AstraZeneca Pharmaceuticals LP $27.87 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104610368 AstraZeneca Pharmaceuticals LP $16.98 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104649179 AstraZeneca Pharmaceuticals LP $17.52 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104703421 AstraZeneca Pharmaceuticals LP $98.53 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104763460 AstraZeneca Pharmaceuticals LP $17.33 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105415648 AstraZeneca Pharmaceuticals LP $23.26 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111669020 Amgen Inc. $20.66 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111669022 Amgen Inc. $20.99 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111669024 Amgen Inc. $25.19 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114130385 Regeneron Healthcare Solutions, Inc. $28.87 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114130387 Regeneron Healthcare Solutions, Inc. $32.47 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114130389 Regeneron Healthcare Solutions, Inc. $13.69 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118225233 Boehringer Ingelheim Pharmaceuticals, Inc. $20.63 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118225237 Boehringer Ingelheim Pharmaceuticals, Inc. $21.91 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137907944 Electromed, Inc. $13.79 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139750585 SANOFI-AVENTIS U.S. LLC $57.48 08/05/2024 Education Undisputed 01/23/2026 View at CMS
1141715635 Merck Sharp & Dohme LLC $16.50 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.